Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT04123366
Brief Title: Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

First Submitted : October 9, 2019
First Submitted that Met QC Criteria : October 9, 2019
First Posted : October 10, 2019

Last Update Submitted that Met QC Criteria : January 17, 2020
Last Update Posted : January 21, 2020